SINOPHARM GROUP CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.55 HKD | -0.92% |
|
+8.40% | +5.38% |
| 04-26 | Central Bank, Tech Outlooks Lift Major Asian Stock Markets | MT |
| 04-16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| Sales 2024 * | 652B 89.96B 704B 7,204B | Sales 2025 * | 711B 98.07B 768B 7,854B | Capitalization | 62.25B 8.59B 67.26B 688B |
|---|---|---|---|---|---|
| Net income 2024 * | 9.83B 1.36B 10.62B 109B | Net income 2025 * | 10.77B 1.49B 11.64B 119B | EV / Sales 2024 * | 0.1 x |
| Net Debt 2024 * | 3.53B 488M 3.82B 39.05B | Net cash position 2025 * | 9.14B 1.26B 9.87B 101B | EV / Sales 2025 * | 0.07 x |
| P/E ratio 2024 * |
6.34
x | P/E ratio 2025 * |
5.79
x | Employees | 115,959 |
| Yield 2024 * |
4.81% | Yield 2025 * |
5.26% | Free-Float | 42.99% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -0.92% | ||
| 1 week | +8.40% | ||
| Current month | +7.48% | ||
| 1 month | +7.97% | ||
| 3 months | +7.48% | ||
| 6 months | +11.20% | ||
| Current year | +5.38% |
1 week
19.90
22.15
1 month
19.0622.15
Current year
17.4423.00
1 year
17.4428.45
3 years
14.6028.45
5 years
14.6031.40
10 years
14.6045.65
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Liu
PSD | President | 55 | 08/01/09 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 28/02/11 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 30/04/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tak Lung Wu
BRD | Director/Board Member | 57 | 17/09/20 |
Qi Yu Chen
BRD | Director/Board Member | 52 | 30/04/10 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 10/01/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 4 M€ | -27.92% | ||
| 1.36% | 2 M€ | -16.59% | - | |
| 0.48% | 4 M€ | -11.56% | ||
| 0.47% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 21.55 | -0.92% | 8,013,009 |
| 25/04/24 | 21.75 | +0.69% | 4,552,688 |
| 24/04/24 | 21.6 | +3.35% | 7,496,349 |
| 23/04/24 | 20.9 | -0.48% | 2,854,571 |
| 22/04/24 | 21 | +5.63% | 7,177,727 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
12/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.95
CNY
Average target price
25.06
CNY
Spread / Average Target
+25.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.38% | 8.59B | |
| +17.35% | 71.39B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- 1099 Stock
